Stifel Reiterates Buy Rating on Boston Scientific (BSX), 'would not view a cybersecurity-related guidance change as reflecting negatively'
Tweet Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $60.00 price target on Boston Scientific (NYSE: BSX).The analyst commented: "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
